In 2023, pharmaceutical companies AstraZeneca spent over 23 percent of its prescription drug revenues on research and development. In general, big pharmaceutical companies spend around 20 percent of their revenues on research and development.
Global R&D spending
In 2023, the pharmaceutical industry spent some 260 billion U.S. dollars on research and development, which is an increase compared to the previous year. By 2028, expenditures are expected to reach a total of over 300 billion U.S. dollars. Some 22,800 prescription drugs were in the 2024 R&D pipeline, a global number that has been growing with each consecutive year. The drug count has tripled since 2006 and is set to increase even further in the future.
AstraZeneca
AstraZeneca is a British-Swedish multinational pharmaceutical company, based in Cambridge, United Kingdom. One of the company’s top products in 2023 was Tagrisso, which is used in the treatment of certain types of non-small cell lung carcinoma. The product generated 5.8 billion U.S. dollars in revenue that year. Revenue earned through Tagrisso has increased significantly over the last years.
R&D spending as revenue share of leading 10 pharmaceutical companies in 2023
R&D spending as a share of total prescription revenue. The statistic includes the top 10 companies based on prescription drug revenue in 2023.
* This total reflects a $5.5 billion charge for Merck’s collaboration with Daiichi Sankyo, and also includes charges of $11.4 billion in the
aggregate for Merck’s acquisitions of Prometheus Biosciences, Inc. and Imago BioSciences, Inc.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Pharmaceutical Executive. (June 14, 2024). R&D spending as revenue share of leading 10 pharmaceutical companies in 2023 [Graph]. In Statista. Retrieved November 18, 2024, from https://www.statista.com/statistics/309471/randd-spending-share-of-top-pharmaceutical-companies/
Pharmaceutical Executive. "R&D spending as revenue share of leading 10 pharmaceutical companies in 2023." Chart. June 14, 2024. Statista. Accessed November 18, 2024. https://www.statista.com/statistics/309471/randd-spending-share-of-top-pharmaceutical-companies/
Pharmaceutical Executive. (2024). R&D spending as revenue share of leading 10 pharmaceutical companies in 2023. Statista. Statista Inc.. Accessed: November 18, 2024. https://www.statista.com/statistics/309471/randd-spending-share-of-top-pharmaceutical-companies/
Pharmaceutical Executive. "R&d Spending as Revenue Share of Leading 10 Pharmaceutical Companies in 2023." Statista, Statista Inc., 14 Jun 2024, https://www.statista.com/statistics/309471/randd-spending-share-of-top-pharmaceutical-companies/
Pharmaceutical Executive, R&D spending as revenue share of leading 10 pharmaceutical companies in 2023 Statista, https://www.statista.com/statistics/309471/randd-spending-share-of-top-pharmaceutical-companies/ (last visited November 18, 2024)
R&D spending as revenue share of leading 10 pharmaceutical companies in 2023 [Graph], Pharmaceutical Executive, June 14, 2024. [Online]. Available: https://www.statista.com/statistics/309471/randd-spending-share-of-top-pharmaceutical-companies/